Dimension Capital — Full Portfolio

Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Markus Warmuth(M.D., Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)John Castle(Ph.D., Chief Data and Information Officer)Filip Janku(M.D., Ph.D., Chief Medical Officer)Phil Nickson(Ph.D., J.D., Chief Business and Legal Officer)Magnus Walter(DPhil, Chief Technology Officer)

Co-investorsAisling CapitalNew Enterprise Associates (NEA)Versant VenturesHBM PartnersAmzak HealthAvoro Capital Advisors+1 more

San Francisco, US

Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)

BoardJoshua Wolfe(Director)Matt Ocko(Director)Adam Goulborn(Director)

Board seatAdam Goulburn· per SEC Form D · $14M raise · filed Jul 2016

Co-investorsComet Labs

Collaborative scholarly writing tool turned preprint archive, owned by Wiley since 2018.

New York, US

Nathan Jenkins(Executive Officer)Alberto Pepe(Executive Officer, Director)Matteo Cantiello(Director)

BoardDavid Teten(Director)Brian Cohen(Director)

Board seatAdam Goulburn· per SEC Form D · $1.5M raise · filed Jan 2016

Co-investorsFf Venture CapitalNew York Venture PartnersBloomberg Beta

New York, US

Joshua Bruno(Executive Officer, Director)

BoardBrad Gillespie(Director)Ann Lamont(Director)

Board seatAdam Goulburn· per SEC Form D · $30.3M raise · filed Jan 2016

Professional drone racing league whose pilots fly identical custom-built FPV drones on 3D courses broadcast worldwide.

New York, US

Nicholas Horbaczewski(Executive Officer, Director)

Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2019

Co-investorsCerity Partners VenturesChaifetz GroupLux CapitalRSE VenturesCRCM VenturesHearst Ventures

Boulder, US

Board seatZavain Dar· per SEC Form D · $62.5M raise · filed Mar 2023

New York, US

Board seatAdam Goulburn· per SEC Form D · $15.1M raise · filed Jun 2022

NewLimit develops epigenetic reprogramming medicines to extend healthspan and treat age-related diseases at the intersection of computer science and biotechnology.

AI & Machine LearningBiotechLongevitySouth San Francisco, US

Brian Armstrong(Co-founder, Board of Directors)inBlake Byers(Director)inJacob Kimmel(Director)inMichael Polansky(Executive Officer)

Board seatZavain Dar· per SEC Form D

Co-investorsS32Valor Equity Partners8VCAbstract Venturesage1Beyond Capital+6 more

Odyssey Therapeutics develops small molecule and protein therapeutics targeting upstream signaling nodes and innate immune system mechanisms to prevent pathological inflammation.

BiotechMedical DevicesCambridge, US

Gary D Glick(Executive Officer, Director)in

BoardJill Carroll(Director)inCarl Gordon(Director)inValerie Odegard(Director)Jeffrey Leiden(Director)Charles Baum(Director)

Board seatNan Li· per SEC Form D

Co-investorsActivant CapitalBalderton CapitalCatalio Capital Management, LPForesite CapitalGlobal BioAccess FundGreatPoint Ventures+6 more

Pager Health provides a white-label care navigation platform that combines AI with clinicians to help members find, access, and stay engaged with healthcare.

AI & Machine LearningDigital HealthHealthtechNew York, US

Gaspard de Dreuzy(Executive Officer, Director)Phillip Eytan(Executive Officer, Director)Oscar Salazar(Director)Philip Eytan(Executive Officer, Director, Promoter)Walter Jin(Chairman & CEO)inSandy Clarke(Chief Financial Officer)in

Board seatAdam Goulburn· per SEC Form D · $50M raise · filed Jun 2021

Co-investorsHealth Catalyst CapitalNew Enterprise Associates (NEA)Streamlined VenturesMontage Ventures

San Francisco, US

Shashank Samala(Cofounder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Executive Officer)

Board seatZavain Dar· per SEC Form D · $20.7M raise · filed Aug 2017

Co-investorsGrit VenturesKeiretsu ForumLux CapitalPoint72 VenturesSQN Venture Partners, LLCUncork Capital+1 more

Variant Bio is a therapeutics company that uses human genomics to guide drug development, drawing on expertise across genetics, molecular biology, therapeutics, anthropology, and ethics.

AI & Machine LearningBiotechDigital HealthNew York, US

Kaja Wasik(Executive Officer, Director)Andrew Farnum(Chief Executive Officer)Stephane Castel(Co-Founder, Chief Scientific & Technology Officer)inCraig Basson(Chief Medical Officer, President of R&D)Holly Vance(Chief Operating Officer)

BoardJulie Sunderland(Director)

Board seatAdam Goulburn· per SEC Form D · $31.5M raise · filed Oct 2019

Co-investorsAlta PartnersGeneral CatalystLux CapitalSoftBank Vision Fund

Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design.

AI & Machine LearningBiotechDeep Tech

John Chodera(President / CEO)inTheofanis Karaletsos

BoardZavain Dar(Board)in

Co-investorsCompoundNVIDIAAmplify PartnersDIMENSIONNVentures

AllStripes was a health technology company that built a research platform for rare diseases, collecting and de-identifying patients' medical records to power rare disease research.

Digital HealthHealthtech

Nancy Yu(Founder)in

Co-investorsGaruda VenturesJAZZ Venture PartnersLux CapitalMaveronShasta VenturesSpark Capital

Aspect Biosystems develops bioprinted tissue therapeutics using a platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and biomaterials to create implantable allogeneic tissues.

AI & Machine LearningBiotechLongevity

Tamer Mohamed(Founder & CEO)inSam Wadsworth(Co-founder & Chief Scientific Officer)inSimon Beyer(Co-founder & Chief Technology Officer)inLeela Paris(Chief Technical Operations Officer)inMike Scott(Chief Development Officer)inRay Smith(Chief Financial Officer)in

Co-investorsAngel ForumCivilization Ventures Management, LlcInBC Investment Corp.JDRF T1D FundPage One VenturesPallasite Ventures+4 more

Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareHealthtechLegalTechRoboticsSaaSLondon, GB

Mostafa ElSayed(CEO and Co-Founder)inSuryansh Chandra(Co-Founder)

Co-investorsAir Street CapitalBlue Wire CapitalEntrepreneur FirstHCVCHummingbird VenturesIn-Q-Tel+6 more

Axi.om uses agentic intelligence and AI to predict, explain, and fix drug toxicity early in development by leveraging the largest experimental-to-clinical dataset of profiled molecules linked to human clinical outcomes.

AI & Machine LearningBiotechMedical Devices

Co-investorsAbstract VenturesAmplify PartnersCRV (Charles River Ventures)Inception Studio CapitalAtria Ventures

Chai Discovery builds a computer-aided design suite using artificial intelligence to design new molecules and drugs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Joshua Meier(Founder & CEO)inJack Dent(Founder)in

Co-investorsAmplify PartnersAvenir Growth CapitalBain Capital VenturesBattery VenturesDCVC (Data Collective)General Catalyst+12 more

Convoke offers an AI platform that ingests and structures data from documents, scientific literature, SEC filings, and clinical data, and deploys custom agents to automate knowledge tasks and generate reports, manuscripts, and landscape analyses.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaS

Co-investorsAudaciousKleiner PerkinsACMEComma CapitalLux CapitalNot Boring Capital

Clinical-stage biotech using AI and metabolomics to decode natural chemistry and discover small-molecule medicines.

Viswa Colluru, PhD(Founder)in

Co-investorsAir Street CapitalCatalio Capital Management, LPFPVHummingbird VenturesJAZZ Venture PartnersKinnevik+6 more

Fiveonefour builds tooling focused on agent experience (AX), helping developers ship software that AI agents can use effectively.

AI & Machine LearningDeveloper ToolsSaaSPortland, US

Timote Gelinas Delisle(Executive Officer, Director, Promoter)Chris Crane(Founder)inNicolas Joseph(Founder)inChristopher M Crane(Director)

BoardNan Li(Director)

Co-investorsFlybridge Capital PartnersVermilion Cliffs VenturesRidge VenturesStage 2 Capital

Modal provides a serverless cloud platform designed for data, AI, and machine learning applications, enabling developers to scale from zero to thousands of CPUs or GPUs with simple code.

AI & Machine LearningCloud ComputingDeveloper ToolsNew York, US

Erik BernhardssonAkshat Bubna(Founder)

Co-investorsAmplify PartnersLux CapitalRedpoint VenturesCreandumGeneral CatalystAbstraction Capital+8 more

Kaleidoscope provides a software platform for scientific R&D teams to track and communicate project data, manage complex research processes, and accelerate decision-making.

BiotechEnterprise SoftwareSaaSNew York City, US

Ewan Taylor(CSO and Co-founder)Geraldine Paulus(Co-founder, VP Operations)Brian Naughton(Co-founder and CTO)inDavid Yen(Founder)Bogdan Knezevic(Founder)in

Co-investorsAIN VenturesBurda Principal InvestmentsHAWKTAILHummingbird VenturesRally Ventures Management, Llc

Kimia develops a drug discovery platform called ATLAS that combines active learning, automated chemical synthesis, high-throughput screening, and machine learning to design and optimize novel drug molecules.

AI & Machine LearningBiotechDeep Tech

Stig Hansen(Founder)in

Co-investorsHorizons VenturesThe Column GroupAirTree VenturesBlackbird VenturesDIMENSIONSkip Capital

Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma.

AI & Machine LearningBiotechData & InfrastructureDeveloper ToolsEnterprise SoftwareHealthtechMunich, DE

Alex Wolf(Co-Founder & CEO)inSunny Sun(Founder)inFrederic Enard(Co-CTO & Founding Engineer)

Co-investorsY Combinator

Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.

AI & Machine LearningBiotechMedical Devices

Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)

Co-investorsAIX VenturesFoothill VenturesMitsui Global InvestmentAxial VCBoxOne VenturesCaffeinated Capital+1 more

Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSSan Francisco, US

Deniz Kavi(Co-founder & CEO)inSherry Liu(Founder)in

Co-investorsTreeo VCY Combinator468 Capital